IP Library Granted Patent US 7,417,068
Granted Patent B2
US 7,417,068 · App. 10/964,831 · Granted Aug 26, 2008

EP

Assignee: Asterand UK Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,417,068
App. No.
10/964,831
Granted
Aug 26, 2008
Kind
B2
Abstract

A compound of formula (I): or a salt, solvate and chemically protected form thereof, wherein one of R 2 and R 5 is: (i) H or an optionally substituted C 1-4 alkyl group; or (ii)an optionally substituted C 5-7 aryl; and the other of R 2 and R 5 is the other group; m and n can be 0 or 1, and m+n=1 or 2 R N is H or optionally substituted C 1-4 alkyl R 3 is either: (i) carboxy; (ii) a group of formula (II): (iii) a group of formula (III): wherein R is optionally substituted C 1-7 alkyl, C 5-20 aryl, or NR N3 R N4 , where R N3 and R N4 are independently selected from optionally substituted C 1-4 alkyl; or (iv) tetrazol-5-yl.

Claims (24)

1. A compound of formula (I):

or a salt, solvate and chemically protected form thereof, wherein:

either R 2 is H or an optionally substituted C 1-4 alkyl group and R 5 is an optionally substituted C 5-7 aryl; or

R 5 is H or an optionally substituted C 1-4 alkyl group and R 2 is an optionally substituted C 5-7 aryl;

m and n can be 0 or 1, and m+n=1 or 2

R N is H or optionally substituted C 1-4 alkyl

R 3 is either:

a group of formula (II): or

a group of formula (III):

wherein R is optionally substituted C 1-7 alkyl, C 5-20 aryl, or NR N3 R N4 , where R N3 and R N4 are independently selected from optionally substituted C 1-4 alkyl.

2. A compound according to claim 1 , wherein R 5 is the optionally substituted C 5-7 aryl group and R 2 is H or the optionally substituted C 1-4 alkyl group.

3. A compound according to claim 2 , wherein R 2 is selected from H or an optionally substituted C 1-3 alkyl group.

4. A compound according to claim 3 , wherein R 2 is a methyl group.

5. A compound according to claim 2 , wherein R 5 is a C 6 aryl group.

6. A compound according to claim 5 , wherein R 5 is phenyl.

7. A compound according to claim 1 wherein the C 5-7 aryl group is substituted by substituents selected from C 1-7 alkoxy groups.

8. A compound according to claim 1 , wherein R is selected from an optionally substituted C 5-20 aryl group, and an optionally substituted C 5-20 aryl-C 1-7 alkyl group.

9. A compound according to claim 1 , wherein R is a C 1-7 alkyl group.

10. A compound according to claim 1 , wherein n+m=1.

11. A compound according to claim 10 , wherein n is 0 and m is 1.

12. A compound according to claim 1 , wherein R N is H or methyl.

13. A pharmaceutical composition comprising a compound according to claim 1 or a pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable carrier or diluent.

14. A method of treating a headache disorder comprising administering to a patient in need of treatment an effective amount of a compound of claim 1 or a pharmaceutically acceptable salt thereof.

15. A method according to claim 14 , wherein the headache disorder is a migraine.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2012
From: ASTERAND UK LIMITED
To: ASTERAND UK ACQUISITION LIMITED
Reel/Frame 029158/0380 →
CHANGE OF NAME Recorded Jun 25, 2008
From: PHARMAGENE LABORATORIES LIMITED
To: ASTERAND UK LIMITED
Reel/Frame 021146/0534 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2005
From: CLARK, DAVID EDWARD; HARRIS, NEIL VICTOR; FENTON, GARRY; HYND, GEORGE; STUTTLE, KEITH ALFRED JAMES; SUTTON, JONATHAN MARK; ARGENTA DISCOVERY LIMITED (8/9 SPIRE GREEN CENTRE, FLEX MEADOW, HARLOW, ESSEX, GREAT BRITAIN CM19 5TR)
To: PHARMAGENE LABORATORIES LIMITED
Reel/Frame 016199/0371 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2005
From: DAVIS, RICHARD JON; COLEMAN, ROBERT ALEXANDER; CLARK, KENNETH LYLE; OXFORD, ALEXANDER WILLIAM
To: PHARMAGENE LABORATORIES LIMITED
Reel/Frame 016204/0075 →
Priority Claims (1)
GB 0324269.0 · Oct 16, 2003 · national
Continuity (2)
Provisional Application 6051220000 · Oct 20, 2003
Related Publication 20050124676A1 · Jun 9, 2005